星空体育官方入口网站网址大全-登录入口官网

#黄斑水肿#

43篇内容 | 1588人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2188717, encodeId=74612188e177b, content=<a href='/topic/show?id=b081e6760b8' target=_blank style='color:#2F92EE;'>#糖尿病肾病#</a> <a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=Int J Ophthalmol：黄斑水肿合并糖尿病肾病的玻璃体注射治疗, objectType=article, longId=814300, objectId=883d8143006b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867676002_4754896.png, objectUrl=/article/show_article.do?id=883d8143006b, replyNumber=0, likeNumber=52, createdTime=2024-02-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=883d8143006b, moduleTitle=Int J Ophthalmol：黄斑水肿合并糖尿病肾病的玻璃体注射治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=883d8143006b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1510927, encodeId=846b151092e5a, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=罗氏 (Roche) 的双特异性Vabysmo获得FDA批准用于湿性AMD、糖尿病性黄斑水肿, objectType=article, longId=295101, objectId=9181295101bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9181295101bf, replyNumber=0, likeNumber=66, createdTime=2022-02-05, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9181295101bf, moduleTitle=罗氏 (Roche) 的双特异性Vabysmo获得FDA批准用于湿性AMD、糖尿病性黄斑水肿, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9181295101bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510926, encodeId=cf501510926c0, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=Lancet：双特异性抗体faricimab在湿性或新生血管性年龄相关性黄斑变性（AMD）和糖尿病性黄斑水肿（DME）1年的随访结果, objectType=article, longId=294903, objectId=5c2c29490389, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c2c29490389, replyNumber=0, likeNumber=34, createdTime=2022-01-31, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c2c29490389, moduleTitle=Lancet：双特异性抗体faricimab在湿性或新生血管性年龄相关性黄斑变性（AMD）和糖尿病性黄斑水肿（DME）1年的随访结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5c2c29490389)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510925, encodeId=8ad11510925a1, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=诺华宣布FDA接受Beovu治疗糖尿病黄斑水肿患者的申请, objectType=article, longId=218746, objectId=47b2218e46d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47b2218e46d3, replyNumber=0, likeNumber=66, createdTime=2021-10-18, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47b2218e46d3, moduleTitle=诺华宣布FDA接受Beovu治疗糖尿病黄斑水肿患者的申请, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=47b2218e46d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510924, encodeId=86151510924a6, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=长效双特异性抗体faricimab用于特定黄斑变性和糖尿病性黄斑水肿，4个月注射一次，效果出色, objectType=article, longId=207129, objectId=d13920e12909, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d13920e12909, replyNumber=0, likeNumber=56, createdTime=2021-02-16, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d13920e12909, moduleTitle=长效双特异性抗体faricimab用于特定黄斑变性和糖尿病性黄斑水肿，4个月注射一次，效果出色, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d13920e12909)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510923, encodeId=037a151092335, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=罗氏的Faricimab在糖尿病性黄斑水肿研究中大获成功, objectType=article, longId=205045, objectId=31af20504527, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31af20504527, replyNumber=0, likeNumber=68, createdTime=2021-01-01, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31af20504527, moduleTitle=罗氏的Faricimab在糖尿病性黄斑水肿研究中大获成功, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=31af20504527)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510922, encodeId=96b01510922fa, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=全新糖尿病性黄斑水肿（DME）筛查模型，简单高效助力大规模早筛, objectType=article, longId=204074, objectId=deee2040e43f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deee2040e43f, replyNumber=0, likeNumber=61, createdTime=2020-12-04, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deee2040e43f, moduleTitle=全新糖尿病性黄斑水肿（DME）筛查模型，简单高效助力大规模早筛, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=deee2040e43f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510921, encodeId=25f71510921b9, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=全球不依赖眼底成像的糖尿病性黄斑水肿预测模型重磅发布，提升DME筛查效率，助力糖尿病综合管理, objectType=article, longId=204068, objectId=b2a120406857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2a120406857, replyNumber=0, likeNumber=56, createdTime=2020-12-04, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2a120406857, moduleTitle=全球不依赖眼底成像的糖尿病性黄斑水肿预测模型重磅发布，提升DME筛查效率，助力糖尿病综合管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b2a120406857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510920, encodeId=b883151092027, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=ASRS 2020：OPT-302治疗糖尿病黄斑水肿取得积极进展, objectType=article, longId=198164, objectId=1b5819816444, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b5819816444, replyNumber=0, likeNumber=63, createdTime=2020-07-29, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b5819816444, moduleTitle=ASRS 2020：OPT-302治疗糖尿病黄斑水肿取得积极进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1b5819816444)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510919, encodeId=f4c71510919da, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=KSI-301治疗湿性AMD、糖尿病性黄斑水肿和视网膜静脉阻塞的Ib期临床试验取得积极结果, objectType=article, longId=187876, objectId=f10618e87660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f10618e87660, replyNumber=0, likeNumber=66, createdTime=2020-02-13, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f10618e87660, moduleTitle=KSI-301治疗湿性AMD、糖尿病性黄斑水肿和视网膜静脉阻塞的Ib期临床试验取得积极结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f10618e87660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510918, encodeId=fd1d151091813, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=DIABETOLOGIA：抗富马酸酶抗体促进糖尿病性黄斑水肿中感光细胞内外节段的脱落, objectType=article, longId=163580, objectId=c57516358096, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c57516358096, replyNumber=0, likeNumber=50, createdTime=2019-04-05, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c57516358096, moduleTitle=DIABETOLOGIA：抗富马酸酶抗体促进糖尿病性黄斑水肿中感光细胞内外节段的脱落, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c57516358096)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510917, encodeId=08d2151091ef2, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=Klin Monbl Augenheilkd：阿柏西普对视网膜中央静脉阻塞后黄斑水肿的治疗效果, objectType=article, longId=161126, objectId=f754161126ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f754161126ef, replyNumber=0, likeNumber=61, createdTime=2019-02-27, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f754161126ef, moduleTitle=Klin Monbl Augenheilkd：阿柏西普对视网膜中央静脉阻塞后黄斑水肿的治疗效果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f754161126ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510916, encodeId=d6801510916f6, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=Rom J Ophthalmol：用筋膜下注射曲安奈德治疗继发于旋转萎缩的囊样黄斑水肿, objectType=article, longId=156605, objectId=69d91566050d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69d91566050d, replyNumber=0, likeNumber=89, createdTime=2018-12-26, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69d91566050d, moduleTitle=Rom J Ophthalmol：用筋膜下注射曲安奈德治疗继发于旋转萎缩的囊样黄斑水肿, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=69d91566050d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510915, encodeId=edaf1510915e9, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=PLoS One：糖尿病性黄斑水肿患者房水中的细胞因子水平对抗VEGF治疗, objectType=article, longId=149260, objectId=e98c1492604b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e98c1492604b, replyNumber=0, likeNumber=50, createdTime=2018-09-22, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e98c1492604b, moduleTitle=PLoS One：糖尿病性黄斑水肿患者房水中的细胞因子水平对抗VEGF治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e98c1492604b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510914, encodeId=88ab15109142a, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=Ophthalmologica：具有浆液性视网膜脱离的糖尿病黄斑水肿的新型生物标志物-血清几丁质酶-3样蛋白1, objectType=article, longId=147859, objectId=569314e859ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=569314e859ad, replyNumber=0, likeNumber=59, createdTime=2018-09-01, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=569314e859ad, moduleTitle=Ophthalmologica：具有浆液性视网膜脱离的糖尿病黄斑水肿的新型生物标志物-血清几丁质酶-3样蛋白1, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=569314e859ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510913, encodeId=23e51510913fa, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=Ophthalmologica：地塞米松玻璃体内注射治疗糖尿病性黄斑水肿患者的临床决策, objectType=article, longId=134586, objectId=82cb1345863b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82cb1345863b, replyNumber=0, likeNumber=62, createdTime=2018-04-10, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82cb1345863b, moduleTitle=Ophthalmologica：地塞米松玻璃体内注射治疗糖尿病性黄斑水肿患者的临床决策, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=82cb1345863b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510912, encodeId=97311510912b1, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=Jpn J Ophthalmol：黄斑水肿与视网膜静脉阻塞相关的视力丧失机制, objectType=article, longId=133576, objectId=db5f1335e647, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db5f1335e647, replyNumber=0, likeNumber=59, createdTime=2018-03-28, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db5f1335e647, moduleTitle=Jpn J Ophthalmol：黄斑水肿与视网膜静脉阻塞相关的视力丧失机制, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=db5f1335e647)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510911, encodeId=5fe9151091115, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=BMJ Case Rep：玻璃体内贝伐单抗用于治疗黄热病性视网膜炎：一种新的解决黄斑水肿的方法, objectType=article, longId=128147, objectId=040712814edd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=040712814edd, replyNumber=0, likeNumber=59, createdTime=2018-01-31, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=040712814edd, moduleTitle=BMJ Case Rep：玻璃体内贝伐单抗用于治疗黄热病性视网膜炎：一种新的解决黄斑水肿的方法, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=040712814edd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510910, encodeId=b7e61510910f0, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=Am J Med Sci:中国人中骨质代谢标志物与糖尿病视网膜病变和糖尿病性黄斑水肿之间的相关性研究！, objectType=article, longId=120647, objectId=394612064e37, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=394612064e37, replyNumber=0, likeNumber=46, createdTime=2017-11-20, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=394612064e37, moduleTitle=Am J Med Sci:中国人中骨质代谢标志物与糖尿病视网膜病变和糖尿病性黄斑水肿之间的相关性研究！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=394612064e37)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510909, encodeId=88491510909a0, content=<a href='/topic/show?id=abd8103141b8' target=_blank style='color:#2F92EE;'>#黄斑水肿#</a>, objectTitle=Ophthalmologica：视网膜中心静脉阻塞导致黄斑水肿的抗血管内皮生长因子治疗方案比较研究！, objectType=article, longId=115307, objectId=dabb11530e33, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dabb11530e33, replyNumber=0, likeNumber=33, createdTime=2017-10-08, rootId=0, userName=xiay994456, userId=8b9a10269982, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dabb11530e33, moduleTitle=Ophthalmologica：视网膜中心静脉阻塞导致黄斑水肿的抗血管内皮生长因子治疗方案比较研究！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dabb11530e33)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

黄斑水肿

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#糖尿病肾病# #黄斑水肿#

Int J Ophthalmol：黄斑水肿合并糖尿病肾病的玻璃体注射治疗

2024-02-22发表于上海

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

罗氏 (Roche) 的双特异性Vabysmo获得FDA批准用于湿性AMD、糖尿病性黄斑水肿

2022-02-05

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

Lancet：双特异性抗体faricimab在湿性或新生血管性年龄相关性黄斑变性（AMD）和糖尿病性黄斑水肿（DME）1年的随访结果

2022-01-31

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

诺华宣布FDA接受Beovu治疗糖尿病黄斑水肿患者的申请

2021-10-18

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

长效双特异性抗体faricimab用于特定黄斑变性和糖尿病性黄斑水肿，4个月注射一次，效果出色

2021-02-16

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

罗氏的Faricimab在糖尿病性黄斑水肿研究中大获成功

2021-01-01

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

全新糖尿病性黄斑水肿（DME）筛查模型，简单高效助力大规模早筛

2020-12-04

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

全球不依赖眼底成像的糖尿病性黄斑水肿预测模型重磅发布，提升DME筛查效率，助力糖尿病综合管理

2020-12-04

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

ASRS 2020：OPT-302治疗糖尿病黄斑水肿取得积极进展

2020-07-29

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

KSI-301治疗湿性AMD、糖尿病性黄斑水肿和视网膜静脉阻塞的Ib期临床试验取得积极结果

2020-02-13

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

DIABETOLOGIA：抗富马酸酶抗体促进糖尿病性黄斑水肿中感光细胞内外节段的脱落

2019-04-05

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

Klin Monbl Augenheilkd：阿柏西普对视网膜中央静脉阻塞后黄斑水肿的治疗效果

2019-02-27

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

Rom J Ophthalmol：用筋膜下注射曲安奈德治疗继发于旋转萎缩的囊样黄斑水肿

2018-12-26

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

PLoS One：糖尿病性黄斑水肿患者房水中的细胞因子水平对抗VEGF治疗

2018-09-22

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

Ophthalmologica：具有浆液性视网膜脱离的糖尿病黄斑水肿的新型生物标志物-血清几丁质酶-3样蛋白1

2018-09-01

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

Ophthalmologica：地塞米松玻璃体内注射治疗糖尿病性黄斑水肿患者的临床决策

2018-04-10

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

Jpn J Ophthalmol：黄斑水肿与视网膜静脉阻塞相关的视力丧失机制

2018-03-28

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

BMJ Case Rep：玻璃体内贝伐单抗用于治疗黄热病性视网膜炎：一种新的解决黄斑水肿的方法

2018-01-31

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

Am J Med Sci:中国人中骨质代谢标志物与糖尿病视网膜病变和糖尿病性黄斑水肿之间的相关性研究！

2017-11-20

xiay994456 (审核中...)

前往app查看评论内容

#黄斑水肿#

Ophthalmologica：视网膜中心静脉阻塞导致黄斑水肿的抗血管内皮生长因子治疗方案比较研究！

2017-10-08

科室
- - 订阅+
  - 更多科室
工具
服务